Grastofil (filgrastim)

pCPA File Number: 20898

Negotiation Status:

Concluded with an LOI

Indication(s):

Neutropenia in various indications (Prevention or treatment)

Sponsor/Manufacturer:

ApoPharm Inc.

CDA-AMC Project Number:

SE0446-000

pCPA Engagement Letter Issued:

2016-06-15

Negotiation Process Concluded:

2016-12-12